Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

Again, if GNBT Qs being fielded - In addition to

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36568
(Total Views: 337)
Posted On: 07/08/2020 10:49:09 AM
Posted By: Buildit
Again, if GNBT Qs being fielded - In addition to the potentially “100s of millions of dollars” which would presumably be accessible to GNBT thru sales of free-trading, NASDAQ-listed NGIO stock, there are currently at least (3) S-1s submitted for GNBT funding:

A). Up to 1,000,000 preferred shares raising $33MM

B). $10MM thru issuance of common stock and an additional $12.5MM if warrants are exercised, and

C). ~37.5MM shares of common thru Oasis puts.

What is the overall strategy of this multi-pronged approach? Was part of this simply to prove removal of the Going Concern, and you would prefer to use the other approaches for the actual funding?

Or is this more of a shotgun approach so you can choose the funding approach that appears to be most favorable at any given time?

Do you see a circumstance where you would pull the trigger on all of these funding initiatives at once (or is that, in fact, the plan)?

Does the submittal of so many funding avenues impact the likelihood or timing of their approval?

Please speak to the funding amount you would need in order to fulfill all of the obligations to close pending acquisitions and “start up the machine” and confirm or discuss your previous statements that there would be $250MM in revenues the 12 months following funding.


(2)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us